SCHEMBL19031886

SCHEMBL19031886

CCC(=O)N(c1ccccc1)c1cncnc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.49
ALDH1A1 P00352 2/20 0.49
HTT P42858 2/20 0.49
POLB P06746 2/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
KMT2A Q03164 1/20 0.49
KCNA5 P22460 1/20 0.43
TSHR P16473 2/20 0.41
GLA P06280 1/20 0.41
TP53 P04637 1/20 0.40
HDAC6 Q9UBN7 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
PAX8 Q06710 1/20 0.38
TACR1 P25103 1/20 0.38
ATR Q13535 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2781437 0.86 ALDH1A1 (0.63) NPSR1ALDH1A1HTTPOLBNPC1
Hydrochloric Acid SCHEMBL27517470 0.84 ALDH1A1 (0.61) NPSR1ALDH1A1HTTPOLBNPC1
SCHEMBL2203788 0.83 KMT2A (0.52) NPSR1ALDH1A1HTTPOLBNPC1
SCHEMBL7982157 0.81 NPSR1 (0.47) NPSR1ALDH1A1HTTPOLBNPC1
SCHEMBL3430030 0.77 NPSR1 (0.47) NPSR1ALDH1A1HTTPOLBNPC1
SCHEMBL28618700 0.76 ALDH1A1 (0.52) NPSR1ALDH1A1HTTPOLBNPC1
SCHEMBL6259046 0.75 HTT (0.50) NPSR1ALDH1A1HTTPOLBNPC1
SCHEMBL6688096 0.73 HPGD (0.49) ALDH1A1POLBNPC1RAB9AKMT2A
SCHEMBL3426753 0.72 MEN1 (0.54) NPSR1ALDH1A1HTTNPC1RAB9A
SCHEMBL9345905 0.72 ALDH1A1 (0.47) NPSR1ALDH1A1HTTPOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3394067-A1 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES Merck Sharp & Dohme Corp. (US) 2018-10-31 EP disclosed
WO-2017112617-A1 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES MERCK SHARP & DOHME CORP. (US) 2017-06-29 WO disclosed